Therapy News and Research

RSS

Researchers receive $3.9 million grant to evaluate effects of e-cigarette flavors on smoking behaviors

A new $3.9 million grant from the U.S. Food and Drug Administration (FDA) will allow researchers with the Center for Tobacco Research at The Ohio State University Comprehensive Cancer Center to evaluate effects of e-cigarette flavors on the smoking behaviors of current adult smokers.

12 Jul 2023

Difficult transmembrane protein targets for therapeutic antibodies

In this interview, News-Medical talks to Sylvia Xie, product scientist at Sino Biological, about the ongoing emergence of transmembrane proteins as targets for therapeutic antibodies.

From Sino Biological Inc. 12 Jul 2023

UCSF's new pain clinic in Walnut Creek offers hope for children with chronic pain

Each year, too many kids in the East Bay suffer needlessly from pain related to long-term serious illness, including migraines, joint and abdominal pain, sickle cell anemia and more. A new UCSF Health pain clinic in Walnut Creek is opening to provide relief.

11 Jul 2023

Prescription stimulants safe for treating ADHD, study finds

Many parents whose kids take prescription stimulants like Ritalin to treat ADHD worry that it could lead to illicit drug use later.

11 Jul 2023

Imperial spinout NK:IO awarded £1.6M Innovate UK New Cancer Therapeutics grant for development of pioneering NK cell therapy

NK:IO, a leader in NK cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumors, today announced it has been awarded £1.6M in grant funding from Innovate UK’s New Cancer Therapeutics program.

From NK:IO Limited 11 Jul 2023

Muscle soothes mind: Exercise training can lower stress-related blood pressure responses

Researchers performed a meta-analysis to elucidate the effects of exercise training on stress-related blood pressure reactivity.

11 Jul 2023

The antibacterial properties of eucalyptus oil against two main oral disease pathogens

Researchers tested the efficacy of Eucalyptus oil again two bacteria responsible for dental caries.

11 Jul 2023

Could neutralizing SARS-CoV-2 monoclonal antibodies pre-exposure prophylaxis be cost-effective in a population at risk for severe COVID-19?

A recent study evaluated the cost-effectiveness of monoclonal antibodies as pre-exposure prophylaxis (PrEP) for COVID-19.

11 Jul 2023

New clinical trial seeks a regenerative pharmaceutical solution for meniscal tears

With support from Amplicore, a University of Cincinnati spinoff biopharmaceutical company, researchers at UC have begun a Department of Defense-funded clinical trial that seeks a regenerative pharmaceutical solution for meniscal tears.

10 Jul 2023

Phosphorothioate backbone modification enhances aptamer-drug conjugate for pancreatic cancer therapy

Pancreatic cancer is a complex and deadly solid tumor that poses significant challenges for both diagnosis and treatment.

10 Jul 2023

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different laboratories, and improve patient care.

10 Jul 2023

High tumor monocyte content linked to better outcomes for esophageal cancer patients

A Ludwig Cancer Research study has discovered that the presence of relatively high numbers of immune cells known as monocytes in tumors is linked to better outcomes in esophageal cancer patients treated with a combination of chemotherapy and immunotherapy, or immunochemotherapy.

10 Jul 2023

Alcohol-related hepatitis hospitalizations increased dramatically during the pandemic

A boom in alcohol sales during the pandemic appears to have had dire consequences for some as hospital admissions for alcohol-related hepatitis, a life-threatening liver inflammation, increased dramatically, according to a study of national hospitalization data.

10 Jul 2023

Biomarkers in the brain could redefine mental health conditions

The study of biomarkers in the brain - powered by cutting-edge machine learning techniques - could redefine the way mental health conditions are categorized and diagnosed and lead to more effective, personalized treatments.

10 Jul 2023

New research sheds light on role of progesterone in breast cancer

A new research perspective was published in Oncotarget's Volume 14 on July 1, 2023, entitled, "Deciphering the mechanisms of action of progesterone in breast cancer."

10 Jul 2023

Study finds critical gaps in care for people with Parkinson's disease

A new study has identified critical gaps in care for people with Parkinson's disease (PD) in the U.S., including disparities affecting women, people of color (those who identify as Asian, Black, Hispanic and Native American) and residents of rural areas.

10 Jul 2023

Do system-level DOAC therapy management services affect anticoagulation outcomes for AF patients compared to usual care?

Researchers compared outcomes related to three direct oral anticoagulant (DOAC) care models.

10 Jul 2023

Lilly granted MHRA marketing authorization in Great Britain for a ground-breaking UC therapy

Eli Lilly and Company announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation (MA) for mirikizumab (OMVOH®) for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

10 Jul 2023

Psilocybin-assisted therapy may provide more cost-effective solution to treating major depression disorder

A new study by leading academics in the psychedelics space finds that psilocybin combined with therapy could be more cost-effective at treating major depression disorders than currently used methods.

10 Jul 2023

New DNA repair test could revolutionize treatment for genetic disorders and cancers

A personalised test that tells how well chemotherapy, radiotherapy or gene therapy will work on individual patients is now approved for UK, US, EU and Japanese patents.

10 Jul 2023

Therapy News and Research

Researchers receive $3.9 million grant to evaluate effects of e-cigarette flavors on smoking behaviors

Difficult transmembrane protein targets for therapeutic antibodies

UCSF's new pain clinic in Walnut Creek offers hope for children with chronic pain

Prescription stimulants safe for treating ADHD, study finds

Imperial spinout NK:IO awarded £1.6M Innovate UK New Cancer Therapeutics grant for development of pioneering NK cell therapy

Muscle soothes mind: Exercise training can lower stress-related blood pressure responses

The antibacterial properties of eucalyptus oil against two main oral disease pathogens

Could neutralizing SARS-CoV-2 monoclonal antibodies pre-exposure prophylaxis be cost-effective in a population at risk for severe COVID-19?

New clinical trial seeks a regenerative pharmaceutical solution for meniscal tears

Phosphorothioate backbone modification enhances aptamer-drug conjugate for pancreatic cancer therapy

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

High tumor monocyte content linked to better outcomes for esophageal cancer patients

Alcohol-related hepatitis hospitalizations increased dramatically during the pandemic

Biomarkers in the brain could redefine mental health conditions

New research sheds light on role of progesterone in breast cancer

Study finds critical gaps in care for people with Parkinson's disease

Do system-level DOAC therapy management services affect anticoagulation outcomes for AF patients compared to usual care?

Lilly granted MHRA marketing authorization in Great Britain for a ground-breaking UC therapy

Psilocybin-assisted therapy may provide more cost-effective solution to treating major depression disorder

New DNA repair test could revolutionize treatment for genetic disorders and cancers

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News